Several angiogenic signalling pathways have been implicated in neuroblastoma progression, including vascular endothelial growth factor (VEGF), the most potent angiogenic growth factor, and the hepatocyte growth factor (HGF) receptor MET [[6], [7], [8]]. Here, MET is linked to neuroblastoma.